In the secondary model specification excluding constituent variables of mSASI and FRS, pre‐treatment mSASI remained positively associated with FRS, although the effect size was smaller and did not reach statistical significance ( β = 0.55, 95% CI –4.6 to 5.7, p = 0.8; Table S1 ). 4 Discussion Cardiovascular risk is an important consideration in the management of OSA, which has been linked to HTN, Afib, other arrhythmias, CHF, CAD, CVA/TIA, T2DM, and metabolic syndrome [ 22 ].
← all excerpts
Modified Sleep Apnea Severity Index and Cardiovascular Risk in CPAP-Intolerant OSA Patients.
1
0.8000
0.8000